The Role of the Tissue Factor Pathway in the Hypercoagulable State in Patients with the Antiphospholipid Syndrome
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Summary: The antiphospholipid syndrome (APS) is characterised by both arterial and venous thrombosis, recurrent pregnancy loss and thrombocytopaenia in association with antiphospholipid antibodies (aPL). To explore further the pathogenesis of thrombosis in APS, we evaluated the behaviour of tissue factor (TF) pathway in patients with APS. Plasma antigen levels of soluble TF and tissue factor pathway inhibitor (TFPI), a physiological regulator of TF dependent coagulation activation, were measured in 57 APS patients (36 primary and 21 secondary to systemic lupus erythematosus). Significantly elevated levels of both TF and TFPI were found in APS patients compared with 25 healthy controls (279 ± 15 vs. 217 ± 17 pg/ml, p = 0.01; 56.24 ± 2.00 vs. 47.92 ± 2.22 ng/ml, p = 0.01, respectively), suggesting in vivo upregulation of TF pathway in patients with APS. By flow-cytometry, monocytes from a healthy donor displayed higher TF antigen expression when incubated in the presence of APS plasmas than in control plasmas (24.23 ± 3.11 vs. 12.78 ± 1.57%, p = 0.002). Peripheral blood mononuclear cells (PBMC) also expressed more procoagulant activity (PCA) when incubated in the presence of APS plasmas than in control plasmas (1.80 ± 0.12 vs. 1.35 ± 0.054, p = 0.001) implying that TF up-regulation in APS was reproducible in vitro. Human monoclonal anticardiolipin antibodies induced PCA on PBMC and also TF mRNA on both PBMC and human umbilical vein endothelial cells shown by reverse-transcription polymerase chain reaction. These data strongly suggest that the TF pathway is implicated in the pathogenesis of aPL related thrombosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Fiers, W., Cotran, R. S., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4533 · Cited by 1,067
Harris, E. N., Gharavi, A. E., Patel, S., & Hughes, G. R. (1987) · PubMed · Cited by 723
Self-citationTissue factor and hemostasis [published erratum appears in Blood 1988 Apr;71(4):1178]
Nemerson, Y. (1988) · Blood · doi:10.1182/blood.v71.1.1.1 · Cited by 682
The antiphospholipid syndrome: ten years on
Hughes, G. R. V. (1993) · The Lancet · doi:10.1016/0140-6736(93)91477-4 · Cited by 621
Self-citationNawroth, P. P., Handley, D. A., Esmon, C. T., & Stern, D. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3460 · Cited by 582
The Structural Biology of Expression and Function of Tissue Factor
Edgington, T. S., Mackman, N., Brand, K., & Ruf, W. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646375 · Cited by 551
Carreras, L., Machin, S., Deman, R., Defreyn, G., Vermylen, J., Spitz, B., & Van Assche, A. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92087-0 · Cited by 551
Cultured human endothelial cells generate tissue factor in response to endotoxin.
Colucci, M., Balconi, G., Lorenzet, R., Pietra, A., Locati, D., Donati, M. B., & Semeraro, N. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110945 · Cited by 500
Oosting, J., Derksen, R., Bobbink, I., Hackeng, T., Bouma, B., & de Groot, P. (1993) · Blood · doi:10.1182/blood.v81.10.2618.2618 · Cited by 488
Broze, G. J., Warren, L., Novotny, W., Higuchi, D., Girard, J., & Miletich, J. (1988) · Blood · doi:10.1182/blood.v71.2.335.335 · Cited by 485
Activation of cultured vascular endothelial cells by antiphospholipid antibodies.
Simantov, R., LaSala, J. M., Lo, S. K., Gharavi, A. E., Sammaritano, L. R., Salmon, J. E., & Silverstein, R. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118276 · Cited by 420
Tissue Factor Pathway Inhibitor
Broze, G. J. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642658 · Cited by 330
Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin.
Gregory, S. A., Morrissey, J. H., & Edgington, T. S. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.6.2752 · Cited by 306
Papa, N. D., Guidali, L., Sala, A., Buccellati, C., Khamashta, M. A., Ichikawa, K., Koike, T., Balestrieri, G., Tincani, A., Hughes, G. R. V., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400322 · Cited by 289
Self-citationRegulation of the tissue factor gene
Mackman, N. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615158 · Cited by 269
Shear stress induction of the tissue factor gene.
Lin, M. C., Almus-Jacobs, F., Chen, H. H., Parry, G. C., Mackman, N., Shyy, J. Y., & Chien, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119219 · Cited by 236
Cuadrado, M. J., López‐Pedrera, C., Khamashta, M. A., Camps, M. T., Tinahones, F., Torres, A., Hughes, G. R. V., & Velasco, F. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400509 · Cited by 232
Self-citationInhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies
Malia, R. G., Kitchen, S., Greaves, M., & Preston, F. E. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb07843.x · Cited by 209
Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies.
Kornberg, A., Blank, M., Kaufman, S., & Shoenfeld, Y. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.3.1328 · Cited by 196
Amengual, O. (1996) · Rheumatology · doi:10.1093/rheumatology/35.12.1239 · Cited by 191
Self-citationSandset, P. M., Warn-Cramer, B. J., Rao, L. V., Maki, S. L., & Rapaport, S. I. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.708 · Cited by 164
Ichikawa, K., Khamashta, M. A., Koike, T., Matsuura, E., & Hughes, G. R. V. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371008 · Cited by 148
Self-citationArnout, J. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650316 · Cited by 147
Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells
Conway, E. M., Bach, R. R., ROSENBERG, R. D., & Konigsberg, W. H. (1989) · Thrombosis Research · doi:10.1016/0049-3848(89)90098-4 · Cited by 146
Branch, D., & Rodgers, G. M. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(12)90915-1 · Cited by 146
Shi, W., Chong, B. H., Hogg, P. J., & Chesterman, C. N. (1993) · PubMed · Cited by 114
Sandset, P., Warn-Cramer, B. J., Maki, S., & Rapaport, S. (1991) · Blood · doi:10.1182/blood.v78.6.1496.1496 · Cited by 110
Ames, P. R. J., Tommasino, C., Iannaccone, L., Brillante, M., Cimino, R., & Brancaccio, V. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650552 · Cited by 108
Platelet Activating Properties of Murine Monoclonal Antibodies to β2-Glycoprotein I
Arvieux, J., Roussel, B., Pouzol, P., & Colomb, M. G. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649576 · Cited by 94
Herbert, J., Savi, P., Laplace, M.-C., & Lalé, A. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81139-d · Cited by 91
Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.
Violi, F., Ferro, D., Valesini, G., Quintarelli, C., Saliola, M., Grandilli, M. A., & Balsano, F. (1990) · BMJ · doi:10.1136/bmj.300.6732.1099 · Cited by 61
Decreased Plasma Tissue Factor Pathway Inhibitor Activity in Ischemic Stroke Patients
Abumiya, T., Yamaguchi, T., Terasaki, T., Kokawa, T., Kario, K., & Kato, H. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649880 · Cited by 47
Bregengaard, C., Nordfang, O., Wildgoose, P., Svendsen, O. L., Hedner, U. K. E., & Diness, V. (1993) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199304050-00005 · Cited by 45
Detection of Circulating Tissue Factor and Factor VII in a Normal Population
Albrecht, S., Kotzsch, M., Siegert, G., Luther, T., Großmann, H., Großer, M., & Müller, M. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650365 · Cited by 41
Up-Regulated Tissue Factor Expression in Antiphospholipid Syndrome
Atsumi, T., Khamashta, M. A., Amengual, O., & Hughes, G. R. V. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655940 · Cited by 33
Self-citationKazama, Y. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655995 · Cited by 11
Cited by
Guidelines on the investigation and management of antiphospholipid syndrome
Keeling, D., Mackie, I., Moore, G. W., Greer, I. A., Greaves, M., & British Committee for Standards in Haematology (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09037.x · Cited by 740
Ritis, K., Doumas, M., Mastellos, D., Micheli, A., Giaglis, S., Magotti, P., Rafail, S., Kartalis, G., Sideras, P., & Lambris, J. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4794 · Cited by 489
Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein
Bogdanov, V. Y., Balasubramanian, V., Hathcock, J., Vele, O., Lieb, M., & Nemerson, Y. (2003) · Nature Medicine · doi:10.1038/nm841 · Cited by 467
Biró, É., Sturk-Maquelin, K. N., Vogel, G. M. T., Meuleman, D. G., Smit, M. J., Hack, C. E., Sturk, A., & Nieuwland, R. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00456.x · Cited by 314
Antiphospholipid antibodies and thrombosis
Greaves, M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10362-8 · Cited by 309
Metadata
- Authors
- Amengual, O., Atsumi, T., Hughes, G., & Khamashta, M.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 1998
- Volume
- 79
- Issue
- 02
- Pages
- 276-281
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W1846075936
- Cited by
- 266
- References
- 37
- FWCI
- 11.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.